Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

NeoPharm receives milestone payment from P&U for LEP

March 20, 2000

Decitabine effective in myelodysplastic syndrome

March 20, 2000

Anticancer activity, pharmacokinetics and safety of E-7869

March 17, 2000

Anti-VEGF antisense oligonucleotides in the Aventis pipeline

March 17, 2000

ImClone achieves milestone in IMC-C225 agreement with Merck KGaA

March 17, 2000

sNDA for Nolvadex in DCIS to undergo priority review

March 17, 2000

EGF receptor tyrosine kinase inhibitor selected for clinical testing at Parke-Davis

March 16, 2000

NIH advisory committee approves phase III protocol for Introgen's p53 gene therapy

March 15, 2000

Orphan Medical's Busulfex approved in Israel

March 15, 2000

Additional mechanism of action revealed for Neovastat

March 15, 2000

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...